Lineage Cell Therapeutics, Inc. (LCTX) Earnings Call Analysis
AMEX · Healthcare · Biotechnology
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Lineage Cell Therapeutics (LCTX) Q1 2026: Alloscope Platform Drives Expansion, $53M Cash Extends Runway
May 13, 2026
-
Lineage Cell Therapeutics (LCTX) Q4 2025: Oprogen Clinical Sites Up 100% as Pipeline Optionality Expands
March 06, 2026
-
Lineage Cell Therapeutics (LCTX) Q3 2025: Oprigen Clinical Sites Surge 8x, Accelerating Platform Expansion
November 07, 2025
-
Lineage Cell Therapeutics (LCTX) Q2 2025: $14.8M Non-Cash Impairment Spotlights Pipeline Refocus and Platform Leverage
August 12, 2025